Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry J M Groen

Showing results (151-160 of 274) with videos related to

Pageof 28
Sort By:
Respiratory Research|January 30, 2013
Low-dose CT measurements of airway dimensions and emphysema associated with airflow limitation in heavy smokers: a cross sectional studyAkkelies E Dijkstra, Dirkje S Postma, Nick ten Hacken, et al.
Respiratory Research|May 22, 2013
Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up studyFirdaus A A Mohamed Hoesein, Pieter Zanen, Pim A de Jong, et al.
Pharmacoeconomics|January 9, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted TherapyZakile A Mfumbilwa, Martijn J H G Simons, Bram Ramaekers, et al.
British Journal of Cancer|December 1, 2021
Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survivalMenno Tamminga, Kiki C Andree, Hilda van den Bos, et al.
Nature Communications|August 28, 2025
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trialsMax Welz, Carlijn M van der Aalst, Andreas Alfons, et al.
Intensive Care Medicine|October 22, 2003
Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patientsClaudi S M Oude Nijhuis, Edo Vellenga, Simon M G J Daenen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2017
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancerJean-Charles Soria, Alex A Adjei, Rastilav Bahleda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2020
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutationPei Meng, Bart Koopman, Klaas Kok, et al.
Clinical Lung Cancer|April 11, 2020
A Subsolid Nodules Imaging Reporting System (SSN-IRS) for Classifying 3 Subtypes of Pulmonary AdenocarcinomaXiaonan Cui, Marjolein A Heuvelmans, Shuxuan Fan, et al.
European Journal of Hybrid Imaging|May 22, 2018
Somatostatin receptor based hybrid imaging in sarcoidosisRiemer H J A Slart, Klaas-Pieter Koopmans, Peter Paul van Geel, et al.
Pageof 28

Showing results (151-160 of 274) with videos related to

Sort By:
Pageof 28
Respiratory Research|January 30, 2013
Low-dose CT measurements of airway dimensions and emphysema associated with airflow limitation in heavy smokers: a cross sectional studyAkkelies E Dijkstra, Dirkje S Postma, Nick ten Hacken, et al.
Respiratory Research|May 22, 2013
Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up studyFirdaus A A Mohamed Hoesein, Pieter Zanen, Pim A de Jong, et al.
Pharmacoeconomics|January 9, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted TherapyZakile A Mfumbilwa, Martijn J H G Simons, Bram Ramaekers, et al.
British Journal of Cancer|December 1, 2021
Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survivalMenno Tamminga, Kiki C Andree, Hilda van den Bos, et al.
Nature Communications|August 28, 2025
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trialsMax Welz, Carlijn M van der Aalst, Andreas Alfons, et al.
Intensive Care Medicine|October 22, 2003
Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patientsClaudi S M Oude Nijhuis, Edo Vellenga, Simon M G J Daenen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2017
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancerJean-Charles Soria, Alex A Adjei, Rastilav Bahleda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2020
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutationPei Meng, Bart Koopman, Klaas Kok, et al.
Clinical Lung Cancer|April 11, 2020
A Subsolid Nodules Imaging Reporting System (SSN-IRS) for Classifying 3 Subtypes of Pulmonary AdenocarcinomaXiaonan Cui, Marjolein A Heuvelmans, Shuxuan Fan, et al.
European Journal of Hybrid Imaging|May 22, 2018
Somatostatin receptor based hybrid imaging in sarcoidosisRiemer H J A Slart, Klaas-Pieter Koopmans, Peter Paul van Geel, et al.
Pageof 28